SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?


To: sam who wrote (733)11/12/1998 9:24:00 AM
From: Steve Valliere  Respond to of 834
 
How will the stock market react to this news? I feel that the extension of warrants by TXB management will give shareholders confidence that Novistran and other drugs in the pipeline will get FDA approval.



To: sam who wrote (733)11/12/1998 9:52:00 PM
From: Cacaito  Read Replies (1) | Respond to of 834
 
Merck has already a very similar compound approved and I think on the market in the USA, or very close to market. TXB has a very tough race ahead.